AstraZeneca Officer Files to Sell $1.3M in Vested Stock
ASTRAZENECA PLC
Subscribe to track AZN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
AstraZeneca Officer Files to Sell $1.3M in Vested Stock
Company: ASTRAZENECA PLC (AZN) Form: 144 | Filed: 2025-11-12 Significance: Low
Insider: ARADHANA SARIN Title: Officer | Relationship: Officer
Transaction: • Type: Proposed Sale • Shares: 15,000 • Price: ~$88.88 • Value: $1,333,200 • Owned After: Not Disclosed
Key Insight: An officer has filed a notice of proposed sale for shares acquired through a restricted stock vesting plan. The transaction value is negligible (<0.001%) compared to AstraZeneca's $271B market cap.
Market Context: This type of sale is common for executives to manage holdings from compensation and is generally not considered a significant market signal for a company of this size.
Comprehensive Analysis
SEC Filing Analysis: ASTRAZENECA PLC (AZN)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer filed a notice of proposed sale for $1.33 million worth of stock, acquired as part of a compensation plan.
- Market Impact: The transaction is negligible relative to the company's market capitalization and is unlikely to have any market impact.
Company Information
| Field | Value |
|---|---|
| Company | ASTRAZENECA PLC |
| Ticker Symbol | AZN |
| CIK | 0000901832 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | ARADHANA SARIN |
| CIK | 0001729110 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-12 |
| Transaction Code | S |
| Security Type | ADR |
| Shares Involved | 15,000 |
| Price Per Share | $88.88 |
| Total Value | $1,333,200 |
| Shares Owned After | Not Disclosed |
| Ownership Type | Not Disclosed |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $1,333,200 |
| % of Market Cap | 0.0005% |
| Shares Transacted | 15,000 |
| % of Shares Outstanding | 0.0005% |
| Post-Transaction Ownership | Not Disclosed |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The $1.33 million proposed sale is trivial for a mega-cap company with a market capitalization of $271.24 billion.
- Ownership Concentration: While post-transaction ownership is not disclosed, a sale of this size is highly unlikely to materially alter the insider's overall stake.
- Dilution Impact: Not applicable, as this is a sale of existing shares, not an issuance.
- Transaction Significance: The transaction is insignificant, representing a tiny fraction of both the market cap and shares outstanding. It is a routine filing for a corporate executive.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale is related to vested compensation from a restricted stock plan. Such sales are common for liquidity and tax purposes and do not typically reflect an insider's negative outlook on the company's future performance. The size is de minimis.
Volume & Sentiment
- Expected Volume Impact: None. The transaction size is too small to have a noticeable effect on the daily trading volume of AZN.
- Sentiment Indicator: Neutral. The market will likely view this as a routine, non-eventful filing.
Additional Context
Transaction Notes
- The filing specifies the shares were acquired via "Restricted stock vesting under a registered plan" and the nature of payment was "Compensation". This strongly suggests the sale is a non-discretionary event to either cover taxes upon vesting or for personal liquidity planning.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
